Cargando…
A Naturally Occurring Variant in Human TLR9, P99L, Is Associated with Loss of CpG Oligonucleotide Responsiveness
The innate immune system employs Toll-like receptors (TLRs) for the detection of invading microorganisms based on distinct molecular patterns. For example, TLR9 is activated by microbial DNA and also by short therapeutic CpG-containing oligonucleotides (CpG-ODN). TLR9 activation leads to the product...
Autores principales: | Kubarenko, Andriy V., Ranjan, Satish, Rautanen, Anna, Mills, Tara C., Wong, Sunny, Vannberg, Fredrik, Neumaier, Michael, Bekeredjian-Ding, Isabelle, Hill, Adrian V. S., Ahmad-Nejad, Parviz, Weber, Alexander N. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978577/ https://www.ncbi.nlm.nih.gov/pubmed/20843814 http://dx.doi.org/10.1074/jbc.M110.117200 |
Ejemplares similares
-
CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015) -
CpG oligonucleotides bind TLR9 and RRM-Containing proteins in Atlantic Salmon (Salmo salar)
por: Iliev, Dimitar B, et al.
Publicado: (2013) -
The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018) -
Functional Downregulation of PD-L1 and PD-L2 by CpG and non-CpG Oligonucleotides in Melanoma Cells
por: Kleemann, Johannes, et al.
Publicado: (2022) -
Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs
por: Grajkowski, Andrzej, et al.
Publicado: (2005)